Article | February 3, 2023

Annex 1 – The Brave New World Of Regulatory Compliance

Source: IPS-Integrated Project Services

By Kevin Owen

Compliance GettyImages-1348548209

After six years in draft form, the revision to Annex 1 was finally released in August 2022, and will become effective in August 2023.

Those following the journey of the draft Annex 1 through to fruition have already identified and largely anticipated the changes to the previous Annex 1. Indeed for many pharmaceutical manufacturers, Annex 1 now aligns closer with the technologies and processes they have already built into their manufacturing facilities over the last few years.

For others whom waiting for the Annex 1 to become live has been the modus operandi: now is the time to act. Explore the major changes and considerations along with the next steps to achieve Annex 1 Regulatory compliance.

access the Article!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Cell & Gene? Subscribe today.

Subscribe to Cell & Gene X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.

or

Subscribe to Cell & Gene

IPS-Integrated Project Services